Cystic Fibrosis Canada

2323 Yonge Street, Suite 800
Toronto, ON M4P 2C9
President & CEO: Kelly Grover
Board Chair: Leona Pinsky

Charitable Reg. #:10684 5100 RR0001

STAR RATING

Ci's Star Rating is calculated based on the following independent metrics:

[Charity Rating: 3/5]

✔+

FINANCIAL TRANSPARENCY

Audited financial statements for current and previous years available on the charity’s website.

A

RESULTS REPORTING

Grade based on the charity's public reporting of the work it does and the results it achieves.

n/r

DEMONSTRATED IMPACT

The demonstrated impact per dollar Ci calculates from available program information.

NEED FOR FUNDING

Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.

53%

CENTS TO THE CAUSE

For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 53 cents are available for programs.



My anchor

OVERVIEW

About Cystic Fibrosis Canada:

Cystic Fibrosis Canada is a 3-star rated charity with best practice in financial transparency and above average accountability to donors as seen in the A results reporting grade. For every dollar donated to this charity, 53 cents go to the cause. This falls outside Ci's reasonable range for overhead spending.

Founded in 1960, Cystic Fibrosis Canada (CFC) aims to end cystic fibrosis by funding research for a cure and advocating for high-quality patient care. Cystic fibrosis (CF) is an inherited disease that can cause severe damage to the lungs, digestive tract, and other organs. It involves uncontrolled mucus buildup in the body, which can lead to nutrient deficiencies, chronic infections, and death in most patients. Cystic Fibrosis Canada states that CF is the most common fatal genetic disease affecting Canadian children and young adults. It currently estimates that more than 4,332 Canadians live with CF. CFC’s main office is in Toronto.

Cystic Fibrosis Canada runs four main programs: Research, Healthcare, Education, and Advocacy.

Education programs were 35% of program costs in F2021. CFC maintains the Canadian Cystic Fibrosis Registry, a collection of national CF patient data to measure trends in CF and improve understanding of CF among medical professionals. In F2021, the charity also developed two reports on cystic fibrosis standards of care to expand clinical knowledge.

Research represented 29% of program spending in F2021. CFC’s research funding has resulted in many significant developments in CF research, including the discovery of the CF gene in 1989. In F2021, Cystic Fibrosis Canada funded 26 active clinical trials that saw 185 participants. The charity also published two reports on how covid-19 affects people with cystic fibrosis.

Advocacy represented 20% of program costs in F2021. Cystic Fibrosis Canada runs provincial and national advocacy campaigns to raise awareness and increase support for CF patients. In F2021, the charity sent 224 letters to the editor and 5,500 letters to MPs. The charity also sent 1,850 letters to the Patented Medicine Prices Review Board and secured 40,000 signatures for a petition.

Healthcare programs made up 15% of program costs in F2021. CFC funds a network of 42 CF clinics across Canada. The charity also runs a Healthcare Advisory Council that meets three times a year to provide guidance on issues that affect these clinics. The charity also awarded two fellowship grants to physicians that will specialize in cystic fibrosis care.

The remaining 1% of program spending was allocated to other costs.

My anchor

Results and Impact

Cystic Fibrosis Canada advocates for provincial and federal governments to increase access to CF treatments. Following CFC's advocacy efforts, the Patented Medicine Prices Review Board changes were delayed. Trifakta, a life-saving cystic fibrosis medication was also submitted for Health Canada approval and was granted an aligned review, the fastest route for approval available.

CFC also expanded its clinical trial network, making it accessible to 60% of cystic fibrosis patients in Canada. This has resulted in a 42% increase in clinical trials supported by CFC and an increase of 72% in patient participation.

While Ci highlights these key results, they may not be a complete representation of Cystic Fibrosis Canada’s results and impact.

My anchor

Finances

Cystic Fibrosis Canada reported $10.4m in donations in F2021. Administrative costs are 12% of revenues (less investment income) and fundraising costs are 35% of donations. This results in total overhead spending of 47%. For every dollar donated to the charity, 53 cents go to the cause. This falls outside of Ci’s reasonable range for overhead spending, which has been the case for the past three years.

CFC has $10.5m in total funding reserves, of which $94k is donor-endowed. Excluding donor-endowed funds, the charity can cover 221% or 2.2 years of annual program costs with its reserves.

This charity report is an update that has been sent to Cystic Fibrosis Canada for review. Changes and edits may be forthcoming. 

Updated on July 22, 2022 by Angelina Curwin.

Financial Review


Financial Ratios

Fiscal year ending January
202120202019
Administrative costs as % of revenues 11.8%12.2%18.7%
Fundraising costs as % of donations 35.4%37.0%36.9%
Total overhead spending 47.1%49.2%55.7%
Program cost coverage (%) 220.5%81.3%90.1%

Summary Financial Statements

All figures in $000s
202120202019
Donations 10,37615,36716,099
Government funding 1,46300
Business activities (net) 439451341
Special events 00472
Investment income 18465828
Other income 557572432
Total revenues 13,01917,04817,372
Program costs 4,3095,2254,620
Grants 4185,5997,065
Administrative costs 1,5132,0033,248
Fundraising costs 3,6685,6906,122
Total spending 9,90818,51721,055
Cash flow from operations 3,111(1,469)(3,683)
Capital spending 000
Funding reserves 10,5058,88710,623

Note: Ci included realized and unrealized gains (losses) on investments, affecting total revenues by $194k in F2021, $658k in F2020, and $28k in F2019. Ci included direct fundraising costs, affecting total expenses by $2.0m in F2021, $4.1m in F2020, and $4.6m in F2019. To report on a cash basis, Ci removed amortization from program costs.

Salary Information

Full-time staff: 54

Avg. compensation: $99,097

Top 10 staff salary range:

$350k +
0
$300k - $350k
0
$250k - $300k
0
$200k - $250k
1
$160k - $200k
2
$120k - $160k
4
$80k - $120k
3
$40k - $80k
0
< $40k
0

Information from most recent CRA Charities Directorate filings for F2021

My anchor

Comments & Contact

Comments added by the Charity:

No comments have been added by the charity.

Charity Contact

Website: www.cysticfibrosis.ca
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: 1-800-378-2233

Print  
Image

Charity Intelligence researches Canadian charities for donors to be informed and give intelligently. Our website posts free reports on more than 800 Canadian charities, as well as in-depth primers on philanthropic sectors like Canada’s environment, cancer, and homelessness. Today over 500,000 Canadians use our website as a go-to source for information on Canadian charities reading over 1.6 million charity reports. Through rigorous and independent research, Charity Intelligence aims to assist Canada’s dynamic charitable sector in being more transparent, accountable and focused on results.

 

Be Informed. Give Intelligently. Have Impact

 

Charitable Registration Number: 80340 7956 RR0001